Effects of a high molecular mass Convolvulus arvensis extract on tumor growth and angiogenesis.
P R Health Sci J. 2002 Dec;21(4):323-8.
Meng XL, Riordan NH, Casciari JJ, Zhu Y, Zhong J, González MJ, Miranda-Massari JR, Riordan HD.
Plant materials represent promising sources of anti-cancer agents. We developed and tested a novel extract from the ubiquitous plant Convolvulus arvensis.
MATERIALS AND METHODS:
Convolvulus arvensis components were extracted in boiling water, and small molecules were removed by high-pressure filtration. The extract’s biological activity was assessed by measuring its effects on S-180 fibrosarcoma growth in Kun Ming mice and on heparin-induced angiogenesis in chick embryos. We also examined the extract’s effects on lymphocytes ex vivo and tumor cell growth in vitro.
The extract (primarily proteins and polysaccharides) inhibited tumor growth in a dose-dependent fashion when administered orally. At the highest dose tested, 200 mg/kg/day, tumor growth was inhibited by roughly seventy percent. Subcutaneous or intraperitoneal administration at 50 mg/kg/day also inhibited tumor growth by over seventy percent. The extract’s acute LD50 in Kun Ming mice was 500 mg/kg/day when injected, indicating that tumor growth inhibition occurred at non-toxic doses. It inhibited angiogenesis in chick embryos, improved lymphocyte survival ex vivo, and enhanced yeast phagocytosis, but did not kill tumor cells in culture.
High molecular mass extract deserves further study as an anti-cancer agent.